6472 — Bora Pharmaceuticals Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual cashflow statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,024	1,840	4,064	4,955	5,278
Depreciation
Amortisation
Non-Cash Items	70.6	197	1,269	-1,172	-3,603
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-68.1	-352	-1,325	-3,828	1,742
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,237	2,010	4,614	981	4,504
Capital Expenditures	-364	-193	-1,389	-687	-1,007
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	138	-4,088	-1,069	-9,993	-2,373
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-226	-4,281	-2,458	-10,680	-3,380
Financing Cash Flow Items	-54.3	472	-85.7	-337	-336
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-741	4,595	-2,440	12,071	-1,377
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	241	2,371	-228	2,776	-752